Log in

(BUX) Stock Forecast, Price & News

Today's Range N/A
50-Day Range
MA: $0.16
52-Week Range N/A
Volume11,500 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment. The company has a collaboration with the University of Maryland School of Medicine related to the discovery and validation of BioMark's assays for early lung cancer and monitoring of residual tumor load/activity. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostics & Research



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive BUX News and Ratings via Email

Sign-up to receive the latest news and ratings for BUX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

(BUX) (CNSX:BUX) Frequently Asked Questions

What stocks does MarketBeat like better than (BUX)?

Wall Street analysts have given (BUX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (BUX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of (BUX)'s key competitors?

What other stocks do shareholders of (BUX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (BUX) investors own include Stantec Inc. (STN.TO) (STN) and IQE plc (IQE.L) (IQE).

Who are (BUX)'s key executives?

(BUX)'s management team includes the following people:
  • Mr. Rashid Ahmed Bux, Founder, CEO, Pres & Director
  • Gina Huang, CFO & Project Director
  • Dr. Thomas Malcolm Ph.D., Chief Scientific Officer
  • Neal Kaplan, Chief Financial Officer of US
  • Dr. Daniel Sitar, Principal Scientific Advisor
  • Dr. James Bond, Chief of Surrey Hospital Thoracic Surgery Team, Fraser Health Authority & Surrey Memorial Hospital

What is (BUX)'s stock symbol?

(BUX) trades on the CNSX under the ticker symbol "BUX."

How do I buy shares of (BUX)?

Shares of BUX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is (BUX)'s official website?

The official website for (BUX) is www.biomarkdiagnostics.com.

How can I contact (BUX)?

The company can be reached via phone at 604-370-0779.

This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.